Reblozyl is a standard of care for the first-line treatment of anemia without previous erythropoiesis stimulating agent use
Genomics is transforming the future of modern medicine and treatment modalities across specialties
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
Collaborates with VisionSpring to conduct eye check-up camps for underprivileged children
Aromatic L-amino acid decarboxylase deficiency is a rare genetic disorder that affects the production of some neurotransmitters
Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
NM5072 is an anti-Properdin antibody that selectively blocks the alternative pathway while maintaining the integrity of the classical pathway required for fending off infections
This is the fourth authorized indication in Europe for Reblozyl, a first-in-class treatment for patients with disease-related anemia
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
‘Unmask Anemia’ aims to simplify assessment of iron deficiency anemia risk with an easy online self-test based on common signs and symptoms
Subscribe To Our Newsletter & Stay Updated
